EDGAR Filing Documents for 0001104659-13-071426

Form CORRESP - Correspondence:

SEC Accession No. 0001104659-13-071426

Filing Date

2013-09-20

Accepted

2013-09-20 16:52:34

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	CORRESP	77204
	Complete submission text file	0001104659-13-071426.txt		78119

Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170

Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020

ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations